7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology

美国心脏病学会动脉炎、血栓形成和血管生物学（ATVB）理事会的年度春季会议于2011年12月28日在纽约举行。 美国心脏协会与营养、身体活动和代谢协会（NPAM）联合举办。 美国心脏协会理事会。这次会议的目的是汇集初级和高级科学家， 心血管疾病的临床方面，以促进科学交流， 更快地吸收新知识。通过涵盖 ATVB和NPAM理事会，会议具有更广泛的吸引力，可能提供交流， 这些见解在其他情况下是无法获得的。会议的设计旨在鼓励 这次会议的一个重要组成部分是教育。会议的规模是 小到足以让学生和研究员积极参与海报和口头会议， 来自多个学科的国内外知名科学家。总的来说， 会议是1）促进科学信息和实验战略的交流， 研究人员在不同领域的工作有关心血管疾病; 2）确定和传播 关于新技术的信息，可以促进所有领域的研究; 3）加强转让 将基础科学发现转化为转化/临床前研究，并最终转化为临床应用; 4）提供 学生和研究员的论坛，向有眼光的观众展示数据，鼓励 他们的发展和保留在外地;和5）鼓励调查人员在相关领域成为 了解并促进他们之间的科学合作。该会议自2002年以来每年举行一次。 约有800人出席，其中包括约500个专题介绍。 大小保持不变甚至随时间增加的趋势被认为是持续的迹象， 会议的成功是有保证的。

The annual Spring meeting of the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Council of the American Heart Association is held together with the Nutrition, Physical Activity, and Metabolism (NPAM) Council of AHA. The meeting is intended to bring together junior and senior scientists working on basic and clinical aspects of cardiovascular disease for the purpose of advancing scientific interchange in order to facilitate a more rapid assimilation of new knowledge. By encompassing the many disciplines covered by the ATVB and NPAM councils, the meeting has a broader appeal that potentially provides interchanges and insights that would not otherwise become available. The design of the meeting is planned to encourage interaction and discussion and a key component of this meeting is educational. The size of the meeting is small enough to permit students and fellows to actively participate in poster and oral sessions together with well known national and international scientists from several disciplines. Overall, the specific aims of the conference are 1) to promote the exchange of scientific information and experimental strategies among investigators working in diverse areas pertinent to cardiovascular disease; 2) to identify and disseminate information about novel technologies that can advance research across all areas; 3) enhance the transfer of basic science findings into translational/preclinical studies and ultimately to clinical applications; 4) provide a forum for students and fellows to present data to a discriminating audience with an eye toward encouraging their development and retention in the field; and 5) to encourage investigators in related fields to become acquainted and to promote scientific collaborations among them. This meeting has been held annually since the year 2000, with attendance reaching about 800 participants including about 500 individual presentations. The trend for the size to remain constant and even increase with time is taken as a sign that continued success of the meeting is assured.